EQUUS - - Eq Medical Front -

New re­search from Texas A&M shows that horses who re­ceive daily resver­a­trol sup­ple­men­ta­tion af­ter a steroid in­jec­tion for hock lame­ness do bet­ter than those who re­ceive only an in­jec­tion.

For the study, re­searchers fol­lowed 45 horses who were given in­jec­tions to treat hock lame­ness. For the next four months, half of horses re­ceived an oral sup­ple­ment con­tain­ing resver­a­trol, an an­tiox­i­dant-like com­pound found in the skin of red grapes, twice a day. The re­main­ing horses were given a placebo oral sup­ple­ment. The study was blinded, mean­ing that own­ers and the treat­ing vet­eri­nar­i­ans did not know which of the sup­ple­ments, the resver­a­trol or the placebo, the horses were re­ceiv­ing.

Sixty and 120 days af­ter the hock in­jec­tions, the own­ers were sur­veyed about how their horses were do­ing, in par­tic­u­lar whether the hock lame­ness had been re­duced, stayed the same or had be­come worse. Those whose horses had been given the resver­a­trol sup­ple­ment re­ported an im­prove­ment sig­nif­i­cantly more of­ten than did the own­ers whose horses re­ceived the placebo. Ad­di­tion­ally, the horses given the resver­a­trol sup­ple­ment showed sig­nif­i­cantly greater re­duc­tion in lame­ness at the recheck ve­teri­nary ex­am­i­na­tion, four months af­ter the hock in­jec­tions.

Based on this ev­i­dence, the re­searchers con­clude that the sup­ple­ment “re­sulted in re­duced lame­ness.”

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.